Taho Pharmaceuticals Ltd. (TPE:6467)
204.00
-20.50 (-9.13%)
At close: Nov 19, 2026
Taho Pharmaceuticals Revenue
Taho Pharmaceuticals had revenue of 4.59M TWD in the quarter ending September 30, 2026, with 1,355.47% growth. This brings the company's total for the last twelve months to 6.26M, down -22.69% year-over-year. In the year 2025, Taho Pharmaceuticals had annual revenue of 8.41M. That makes Taho Pharmaceuticals the 45,557th largest company in the world by revenue and 2,188th in Taiwan.
Revenue (ttm)
6.26M
Revenue Growth
-22.69%
P/S Ratio
1,880.24
Revenue / Employee
178.79K
Employees
35
Market Cap
10.69B
Revenue by Geography
- United State 8.33M 99.0%
- Japan 82.00K 1.0%
Fiscal year ended Dec 31, 2025 See the full Taho Pharmaceuticals breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.41M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.07M | -5.29M | -83.23% |
| Dec 31, 2022 | 6.36M | -531.00K | -7.71% |
| Dec 31, 2021 | 6.89M | -5.51M | -44.45% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.